Aspirin in Reduction of Tension II Study

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 290 participants.

Also called NCT01379079

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 290 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01379079
  • EudraCT 2010-024448-13
Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Netherlands (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01379079. Randomized; no masking; primary purpose treatment. Start 2011-04 (registry gives no type); primary completion 2013-10 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Aspirin in Reduction of Tension II Study
Acronym
ASPIRETENSION
Condition
Hypertension
Condition
Cardiovascular Diseases
Intervention (Drug)
Acetylsalicylic acid
Intervention (Drug)
Acetylsalicylic acid lysinate
Lead sponsor
Leiden University Medical Center (class: other)
Collaborator
Netherlands Heart Foundation (class: other)

Record details

Record id
cardio:ct-nct01379079
Content hash
f273a7fafa177ecc204a3cd2d5e8fdb28925306985c0f0ccc4a5eea565feda0e